Data-driven prediction of continuous renal replacement therapy survival.

Journal: Nature communications
PMID:

Abstract

Continuous renal replacement therapy (CRRT) is a form of dialysis prescribed to severely ill patients who cannot tolerate regular hemodialysis. However, as the patients are typically very ill to begin with, there is always uncertainty whether they will survive during or after CRRT treatment. Because of outcome uncertainty, a large percentage of patients treated with CRRT do not survive, utilizing scarce resources and raising false hope in patients and their families. To address these issues, we present a machine learning-based algorithm to predict short-term survival in patients being initiated on CRRT. We use information extracted from electronic health records from patients who were placed on CRRT at multiple institutions to train a model that predicts CRRT survival outcome; on a held-out test set, the model achieves an area under the receiver operating curve of 0.848 (CI = 0.822-0.870). Feature importance, error, and subgroup analyses provide insight into bias and relevant features for model prediction. Overall, we demonstrate the potential for predictive machine learning models to assist clinicians in alleviating the uncertainty of CRRT patient survival outcomes, with opportunities for future improvement through further data collection and advanced modeling.

Authors

  • Davina Zamanzadeh
  • Jeffrey Feng
    Medical & Imaging Informatics Group, University of California, Los Angeles, Los Angeles, 90095, CA, USA.
  • Panayiotis Petousis
    Clinical and Translation Science Institute, University of California, Los Angeles, Los Angeles, 90095, CA, USA.
  • Arvind Vepa
    Department of Computer Science, University of California Los Angeles, Los Angeles, CA, USA.
  • Majid Sarrafzadeh
    Computer Science Department, University of California Los Angeles (UCLA), Los Angeles, CA.
  • S Ananth Karumanchi
    Division of Nephrology and Center for Vascular Biology Research, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215.
  • Alex A T Bui
  • Ira Kurtz
    Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, 90095, CA, USA.